356 related articles for article (PubMed ID: 32244127)
1. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
2. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
4. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
[TBL] [Abstract][Full Text] [Related]
7. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
Ejaz A; Casadaban L; Maker AV
J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
[TBL] [Abstract][Full Text] [Related]
8. Pattern of use of adjuvant chemotherapy for stage II colon cancer: a single-institution experience.
Osarogiagbon RU; Sachdev JC; Khattak AG; Kronish LE
Clin Colorectal Cancer; 2009 Apr; 8(2):94-9. PubMed ID: 19739270
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
10. Treatments for Stage IV Colon Cancer and Overall Survival.
Xu Z; Becerra AZ; Fleming FJ; Aquina CT; Dolan JG; Monson JR; Temple LK; Jusko TA
J Surg Res; 2019 Oct; 242():47-54. PubMed ID: 31071604
[TBL] [Abstract][Full Text] [Related]
11. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
[TBL] [Abstract][Full Text] [Related]
12. Impact of high-risk features for stage II adenocarcinoma of the appendix.
Akce M; Zakka K; Penley M; Jiang R; Khalil L; Alese OB; Shaib WL; Wu C; Behera M; El-Rayes BF
Cancer Treat Res Commun; 2021; 27():100329. PubMed ID: 33609973
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemotherapy decision-making in stage II colon adenocarcinoma associated with patients' age and high-risk factors.
Zheng P; Ye C; Liu H; Gao X; Huang H
Int J Colorectal Dis; 2023 Dec; 39(1):3. PubMed ID: 38091096
[TBL] [Abstract][Full Text] [Related]
15. Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients.
Birkett RT; Chamely E; Concors SJ; Bleier JI; Aarons CB; Shanmugan S; Saur NM; Paulson EC
Clin Colorectal Cancer; 2019 Dec; 18(4):292-300. PubMed ID: 31447135
[TBL] [Abstract][Full Text] [Related]
16. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
[TBL] [Abstract][Full Text] [Related]
17. Postoperative Radiation for Pathologic Stage T4 Colon Cancers Receiving Adjuvant Chemotherapy.
Margalit O; Mamtani R; Lawrence YR; Yang YX; Reiss KA; Golan T; Halpern N; Aderka D; Giantonio B; Shacham-Shmueli E; Boursi B
Clin Colorectal Cancer; 2019 Sep; 18(3):226-230.e2. PubMed ID: 31097386
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy in stage 1 colon cancer: Patient characteristics and survival analysis from the national cancer database.
Hsu AT; Wolf JH; D'Adamo CR; Felton J; Paul S; Kumar P; Mavanur AA
Surg Oncol; 2024 Jun; 54():102075. PubMed ID: 38636304
[TBL] [Abstract][Full Text] [Related]
19. Utilization of Adjuvant Radiotherapy for Resected Colon Cancer and Its Effect on Outcome.
Wegner RE; Abel S; Monga D; Raj M; Finley G; Nosik S; McCormick J; Kirichenko AV
Ann Surg Oncol; 2020 Mar; 27(3):825-832. PubMed ID: 31720934
[TBL] [Abstract][Full Text] [Related]
20. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]